October Pharma S.A.E (EGX:OCPH)

October Pharma S.A.E Ratios and Metrics

Market cap in millions EGP. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 24, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,264	1,310	1,200	1,200	978	600
Market Cap Growth	142.18%	9.14%	0%	22.68%	63.02%	51.52%
Enterprise Value	6,621	1,817	1,518	1,257	1,193	853
Last Close Price	261.00	54.57	48.75	48.75	38.74	23.05

Price Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 24, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
PE Ratio	37.94	9.98	7.98	10.55	8.16	6.80
PS Ratio	4.29	1.07	1.19	1.65	1.49	1.10
PB Ratio	9.44	2.30	2.04	2.82	2.88	2.36
P/TBV Ratio	10.66	2.68	2.41	3.67	4.18	4.25
P/FCF Ratio	17.61	-	10.17	-	4.04	12.59
P/OCF Ratio	16.87	30.29	7.83	-	3.73	11.26

EV Ratios

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 24, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
EV/Sales Ratio	4.53	1.48	1.50	1.73	1.82	1.57
EV/EBITDA Ratio	15.78	5.19	4.61	5.68	5.52	5.20
EV/EBIT Ratio	17.47	5.67	4.94	6.31	6.10	5.88
EV/FCF Ratio	18.61	-	12.87	-	4.92	17.90

Financial Efficiency

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 24, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Debt / Equity Ratio	0.64	0.97	0.55	0.76	0.22	0.98
Debt / EBITDA Ratio	1.01	1.57	0.98	1.46	0.34	1.52
Debt / FCF Ratio	1.20	-	2.75	-	0.31	5.21
Net Debt / Equity Ratio	0.54	0.88	0.47	0.74	0.17	0.97
Net Debt / EBITDA Ratio	0.85	1.43	0.85	1.43	0.27	1.50
Net Debt / FCF Ratio	1.00	-50.91	2.36	-1.71	0.24	5.17
Asset Turnover	1.02	0.96	0.97	0.97	1.13	0.95
Inventory Turnover	2.37	2.89	2.45	1.78	2.15	2.55
Quick Ratio	0.47	0.39	0.56	0.36	0.75	0.31
Current Ratio	1.75	1.44	1.82	1.54	2.17	1.38
Return on Equity (ROE)	28.29%	26.20%	35.89%	34.18%	40.38%	40.64%
Return on Assets (ROA)	16.60%	15.70%	18.38%	16.57%	21.09%	15.84%
Return on Invested Capital (ROIC)	30.13%	24.76%	28.40%	26.38%	31.71%	24.55%
Return on Capital Employed (ROCE)	47.60%	47.00%	45.10%	37.90%	48.80%	44.50%

Yields

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 24, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Earnings Yield	2.64%	11.59%	15.18%	10.90%	12.25%	14.71%
FCF Yield	5.68%	-0.75%	9.83%	-15.42%	24.79%	7.94%
Dividend Yield	-	-	2.56%	-	-	3.25%
Payout Ratio	11.06%	36.54%	9.86%	34.16%	28.54%	16.83%
Total Shareholder Return	-	-	2.56%	-	-	3.25%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 25, 2026

Data Sources Report a data error